Co-Authors
This is a "connection" page, showing publications co-authored by WENDY WOODWARD and RACHEL M. LAYMAN.
Connection Strength
0.515
-
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Breast Cancer Res Treat. 2024 Apr; 204(2):289-297.
Score: 0.237
-
ASO Visual Abstract: Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership-Consensus and Opportunities. Ann Surg Oncol. 2024 Aug 10.
Score: 0.062
-
Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Ann Surg Oncol. 2024 Jul 21.
Score: 0.062
-
Inclusion of premenopausal women in breast cancer clinical trials. Breast. 2022 Dec; 66:204-207.
Score: 0.055
-
Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol. 2022 Oct; 29(10):6381-6392.
Score: 0.054
-
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. BMC Cancer. 2020 May 18; 20(1):430.
Score: 0.046